Ballentine Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $953K | Sell |
19,724
-6,339
| -24% | -$306K | 0.01% | 332 |
|
2025
Q1 | $1.45M | Buy |
26,063
+10,617
| +69% | +$589K | 0.03% | 232 |
|
2024
Q4 | $745K | Buy |
15,446
+2,802
| +22% | +$135K | 0.01% | 342 |
|
2024
Q3 | $729K | Buy |
12,644
+2,296
| +22% | +$132K | 0.01% | 346 |
|
2024
Q2 | $502K | Buy |
10,348
+2,371
| +30% | +$115K | 0.01% | 407 |
|
2024
Q1 | $388K | Buy |
7,977
+539
| +7% | +$26.2K | 0.01% | 458 |
|
2023
Q4 | $370K | Buy |
7,438
+402
| +6% | +$20K | 0.01% | 442 |
|
2023
Q3 | $377K | Buy |
7,036
+600
| +9% | +$32.2K | 0.01% | 379 |
|
2023
Q2 | $347K | Buy |
6,436
+2,696
| +72% | +$145K | 0.01% | 412 |
|
2023
Q1 | $204K | Buy |
+3,740
| New | +$204K | 0.01% | 521 |
|
2022
Q3 | – | Sell |
-5,322
| Closed | -$267K | – | 491 |
|
2022
Q2 | $267K | Sell |
5,322
-3,306
| -38% | -$166K | 0.01% | 345 |
|
2022
Q1 | $443K | Buy |
+8,628
| New | +$443K | 0.01% | 276 |
|
2021
Q4 | – | Sell |
-5,020
| Closed | -$242K | – | 483 |
|
2021
Q3 | $242K | Sell |
5,020
-790
| -14% | -$38.1K | 0.01% | 365 |
|
2021
Q2 | $306K | Sell |
5,810
-717
| -11% | -$37.8K | 0.01% | 315 |
|
2021
Q1 | $323K | Buy |
6,527
+430
| +7% | +$21.3K | 0.01% | 289 |
|
2020
Q4 | $296K | Sell |
6,097
-84
| -1% | -$4.08K | 0.01% | 287 |
|
2020
Q3 | $310K | Buy |
6,181
+208
| +3% | +$10.4K | 0.01% | 288 |
|
2020
Q2 | $305K | Sell |
5,973
-501
| -8% | -$25.6K | 0.01% | 270 |
|
2020
Q1 | $283K | Buy |
6,474
+389
| +6% | +$17K | 0.02% | 255 |
|
2019
Q4 | $305K | Buy |
6,085
+744
| +14% | +$37.3K | 0.01% | 299 |
|
2019
Q3 | $247K | Buy |
5,341
+476
| +10% | +$22K | 0.01% | 327 |
|
2019
Q2 | $210K | Buy |
4,865
+13
| +0.3% | +$561 | 0.01% | 359 |
|
2019
Q1 | $214K | Buy |
+4,852
| New | +$214K | 0.01% | 302 |
|